Sign In
Buy PGNY
$26.28
+0.200 (+0.767%)
At Close: Jun 22, 2026
Why Progyny Caught My Eye; Is It A Buy?
09:10am, Tuesday, 16'th May 2023
Sparsely followed Progyny, Inc. is quietly making industry waves. The target market is in its infant stage with intriguing secular tailwinds.
Progyny, Inc. (PGNY) Q1 2023 Earnings Call Transcript
11:20pm, Monday, 08'th May 2023
Progyny, Inc. (NASDAQ:PGNY ) Q1 2023 Earnings Conference Call May 8, 2023 4:45 PM ET Company Participants James Hart - Investor Relations Pete Anevski - Chief Executive Officer Michael Sturmer - Presi
Progyny, Inc. to Present at Bank of America Health Care Conference 2023
12:00pm, Tuesday, 02'nd May 2023
NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pe
4 Growth Stocks to Buy and Hold Forever
05:35am, Thursday, 27'th Apr 2023
CrowdStrike and Progyny offer best-in-class solutions to two of today's biggest problems. Texas Pacific believes it has 14 years' worth of oil inventory on its land, with a break-even point of only $4
Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
12:00pm, Monday, 20'th Mar 2023
NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that
Want $1 Million in Retirement? Invest $200,000 in These 3 Stocks and Wait a Decade
08:45am, Saturday, 11'th Mar 2023
Doximity's ability to connect physicians with pharmaceuticals and health systems is a wildly prosperous pairing. Medpace's customers could struggle in 2023, but its long-term opportunity will only gro
Why Shares of Progyny Rose 18.4% This Week
05:56pm, Friday, 03'rd Mar 2023
The company reported record revenue at the beginning of the week.
Progyny, Inc. (PGNY) Q4 2022 Earnings Call Transcript
11:32pm, Monday, 27'th Feb 2023
Progyny, Inc. (NASDAQ:PGNY ) Q4 2022 Earnings Conference Call February 27, 2023 4:45 PM ET Company Participants James Hart - Vice President of Investor Relations Peter Anevski - Chief Executive Office
Progyny (PGNY) Q4 Earnings and Revenues Beat Estimates
06:49pm, Monday, 27'th Feb 2023
Progyny (PGNY) delivered earnings and revenue surprises of 50% and 1.47%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Zoom Is Zooming, But This Health-Tech Stock Is Doing Even Better
06:45pm, Monday, 27'th Feb 2023
Big after-hours gains followed a strong day on Wall Street.
Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report?
01:33pm, Monday, 30'th Jan 2023
Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Progyny: Expect Fast Growth Despite A Weak Macro Backdrop
04:24am, Sunday, 29'th Jan 2023
There is a lack of effective solution in standard fertility benefit packages and PGNY is addressing this gap. PGNY's approach drives down the overall cost.
In Search of an Earnings Beat? Play These Top 5 Stocks
09:02am, Thursday, 19'th Jan 2023
These top-ranked stocks are likely to beat on bottom line in their next releases. Tap Yum China (YUMC), Impinj (PI), Five Below (FIVE), Hologic (HOLX) and Progyny (PGNY).
7 Stocks With a Forward P/E of 25 to Run Away From
05:53pm, Monday, 09'th Jan 2023
With a rough 2022 spilling into 2023, we're running into a broad list of stocks to avoid. Especially those in the tech space, where high-profile layoffs have picked up amid a severe slowdown in growth
4 Unstoppable Multibaggers to Buy in 2023 and Hold for the Next Decade
05:57am, Tuesday, 27'th Dec 2022
Three-year revenue growth rates between 39% and 54% are projected, making these stocks prime multibagger candidates.
